Picture of Theratechnologies logo

TH Theratechnologies Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Theratechnologies, fiscal year end - November 30th, USD millions except per share, conversion factor applied.

2019
November 30th
2020
November 30th
2021
November 30th
2022
November 30th
2023
November 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-12.5-22.7-31.7-47.2-24
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items5.276.878.2611.315.2
Unusual Items
Other Non-Cash Items
Changes in Working Capital-3.66-6.270.2428.73-0.241
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-3.39-13.6-14.5-14.7-5.68
Capital Expenditures-3.62-0.032-0.166-0.985-1.82
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items3.494.81-12.39.672.93
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-0.134.78-12.58.681.11
Financing Cash Flow Items-3.42-3.31-7.15-3.97-2.48
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-6.81-7.2334.69.6614.8
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-10.3-15.97.663.4610.2